(Q53357652)

13 May 2018

title

Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma. (English)

1 reference

13 May 2018

author name string

Firat Baytekin

1

1 reference

13 May 2018

Burcin Tuna

2

1 reference

13 May 2018

Ugur Mungan

3

1 reference

13 May 2018

Guven Aslan

4

1 reference

13 May 2018

Kutsal Yorukoglu

5

1 reference

13 May 2018

publication date

27 November 2009

1 reference

13 May 2018

published in

Urologic Oncology

1 reference

13 May 2018

volume

29

1 reference

13 May 2018

issue

5

1 reference

13 May 2018

page(s)

502-507

1 reference

13 May 2018

Prognostic markers in renal cell carcinoma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

The prognostic significance of COX-2 and survivin expression in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

Measurement of Multidrug-Resistance Messenger RNA in Urogenital Cancers; Elevated Expression in Renal Cell Carcinoma is Associated with Intrinsic Drug Resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

P-glycoprotein recognition of substrates and circumvention through rational drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

Prognostic significance of morphologic parameters in renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

Prognostic biomarkers in renal cell carcinoma: relevance of DNA ploidy in predicting disease-related survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

Survivin expression is associated with features of biologically aggressive prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

Immunocytochemical detection of P-glycoprotein: initial expression correlates with survival in renal cell carcinoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

Intrinsic chemotherapy resistance to the tubulin-binding antimitotic agents in renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

99mTc-MIBI scintigraphy in metastatic renal cell carcinoma: clinical validation of the relationship between 99mTc-MIBI uptake and P-glycoprotein expression in tumour tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

Survivin overexpression in hepatocellular carcinoma is associated with p53 dysregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

Structural, functional and therapeutic biology of survivin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

Synergy of interferon-alpha and 5-fluorouracil in human renal cell carcinoma requires p53 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

Detection of drug resistance and P-glycoprotein in human renal cell carcinomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.09.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLONC.2009.09.001

1 reference

13 May 2018

1 reference

13 May 2018